4.8 Article

Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells

Journal

ADVANCED SCIENCE
Volume 9, Issue 30, Pages -

Publisher

WILEY
DOI: 10.1002/advs.202202993

Keywords

angiogenesis; glutamine-fructose-6-phosphate aminotransferase 1; metabolic reprogramming; O-GlcNAcylation; small extracellular vesicles

Funding

  1. National Natural Science Foundation of China [81874092]
  2. Chongqing Science and Technology Bureau [cstc2019jscx-dxwtBX0018]

Ask authors/readers for more resources

This study proposes a novel metabolic link between bladder cancer cells and endothelial cells in the nutrient-scarce tumor microenvironment. The secretion of GFAT1 from bladder cancer cells via small extracellular vesicles reprograms glucose metabolism in endothelial cells, enhancing angiogenesis. Furthermore, O-GlcNAcylation of SerRS in endothelial cells regulates vascular endothelial growth factor transcription and contributes to angiogenesis.
A malformed tumour vascular network provokes the nutrient-deprived tumour microenvironment (TME), which conversely activates endothelial cell (EC) functions and stimulates neovascularization. Emerging evidence suggests that the flexible metabolic adaptability of tumour cells helps to establish a metabolic symbiosis among various cell subpopulations in the fluctuating TME. In this study, the authors propose a novel metabolic link between bladder cancer (BCa) cells and ECs in the nutrient-scarce TME, in which BCa-secreted glutamine-fructose-6-phosphate aminotransferase 1 (GFAT1) via small extracellular vesicles (sEVs) reprograms glucose metabolism by increasing hexosamine biosynthesis pathway flux in ECs and thus enhances O-GlcNAcylation. Moreover, seryl-tRNA synthetase (SerRS) O-GlcNAcylation at serine 101 in ECs promotes its degradation by ubiquitination and impeded importin alpha 5-mediated nuclear translocation. Intranuclear SerRS attenuates vascular endothelial growth factor transcription by competitively binding to the GC-rich region of the proximal promotor. Additionally, GFAT1 knockout in tumour cells blocks SerRS O-GlcNAcylation in ECs and attenuates angiogenesis both in vitro and in vivo. However, administration of GFAT1-overexpressing BCa cells-derived sEVs increase the angiogenetic activity in the ECs of GFAT1-knockout mice. In summary, this study suggests that inhibiting sEV-mediated GFAT1 secretion from BCa cells and targeting SerRS O-GlcNAcylation in ECs may serve as novel strategies for BCa antiangiogenetic therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available